Grand Pharmaceutical Group Ltd
HKEX:512
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Wall Street
Price Targets
Price Targets Summary
Grand Pharmaceutical Group Ltd
According to Wall Street analysts, the average 1-year price target for Grand Pharmaceutical Group Ltd is 12.09 HKD with a low forecast of 11.82 HKD and a high forecast of 12.6 HKD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Grand Pharmaceutical Group Ltd's stock price target?
Price Target
12.09
HKD
According to Wall Street analysts, the average 1-year price target for Grand Pharmaceutical Group Ltd is 12.09 HKD with a low forecast of 11.82 HKD and a high forecast of 12.6 HKD.
What is Grand Pharmaceutical Group Ltd's Revenue forecast?
Projected CAGR
9%
For the last 13 years the compound annual growth rate for Grand Pharmaceutical Group Ltd's revenue is 16%. The projected CAGR for the next 3 years is 9%.
What is Grand Pharmaceutical Group Ltd's Operating Income forecast?
Projected CAGR
16%
For the last 13 years the compound annual growth rate for Grand Pharmaceutical Group Ltd's operating income is 25%. The projected CAGR for the next 4 years is 16%.
What is Grand Pharmaceutical Group Ltd's Net Income forecast?
Projected CAGR
2%
For the last 13 years the compound annual growth rate for Grand Pharmaceutical Group Ltd's net income is 34%. The projected CAGR for the next 3 years is 2%.
